CAS 200815-49-2: Arformoterol tartrate
Description:Arformoterol tartrate is a long-acting beta-2 adrenergic agonist primarily used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is the R-enantiomer of formoterol, which enhances its therapeutic efficacy. This compound acts by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation and improved airflow. Arformoterol tartrate is typically administered via inhalation, allowing for direct delivery to the lungs, which maximizes its therapeutic effects while minimizing systemic side effects. The substance is characterized by its relatively long duration of action, providing sustained relief from bronchospasm. It is important to note that while arformoterol can improve lung function, it is not intended for the immediate relief of acute bronchospasm and should be used as part of a comprehensive treatment plan. As with other beta-agonists, potential side effects may include cardiovascular effects, tremors, and nervousness, necessitating careful monitoring in patients with pre-existing conditions.
Formula:C23H30N2O10
InChI:InChI=1/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;1-,2-/m11/s1
- Synonyms:
- (R,R)-Formoterol tartrate
- N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Arformoterol Fumarate
- N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamide 2,3-dihydroxybutanedioate (salt)
- N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamide 2,3-dihydroxybutanedioate (salt)
- Afromoterol tartrate
![Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]p…](https://static.cymitquimica.com/products/IN/thumb/DA002D1E.jpg)
